Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 2Tumor-Agnostic 1Other hematologic neoplasm 1

Conditions

Sarcopenia 2Liver Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Hand Strength × Gastrointestinal × Clear all
NCT05443230 2023-09-13

Effect of Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment

First Affiliated Hospital of Wenzhou Medical University

Unknown
200 enrolled
Gastrointestinal

Liver Neoplasms, Sarcopenia

NCT05448222 2023-09-13

Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic Therapies

First Affiliated Hospital of Wenzhou Medical University

Unknown
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡